Rachel M. Levine

1.0k citations
22 papers · 571 indexed · 1 hit paper · h-index 12
Topics
RNA Interference and Gene Delivery (7 papers)Advanced biosensing and bioanalysis techniques (5 papers)CRISPR and Genetic Engineering (4 papers)
Partner nations
United StatesNetherlands

In The Last Decade

Rachel M. Levine

22 papers receiving 554 citations

Hit Papers

Ex vivo prime editing of patient haematopoietic stem cell...20232026202420252023255075

Peers

Rachel M. Levine
Comparison fields: 5 of 91
  • Molecular Biology 322
  • Oncology 109
  • Genetics 100
  • Biomaterials 83
  • Biomedical Engineering 65
Replace Elisabeth M. Inman with:
Elisabeth M. Inman United States
Pei Lu United States
Larissa Lezina United Kingdom
Hae Young Ko South Korea
Annat Raiter Israel
Brooke Helfer United States
David W. Meyer United States
Eriya Kenjo Japan
Julia F. Alterman United States
Yunfei Wen United States
Rachel M. Levine relative to Elisabeth M. Inman United States Elisabeth M. Inman's profile →
Citations per field
00.5×6.8×
Elisabeth M. Inman · 1×
Citations per year

Countries citing papers authored by Rachel M. Levine

Since Specialization
Citations

This map shows the geographic impact of Rachel M. Levine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel M. Levine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel M. Levine more than expected).

Fields of papers citing papers by Rachel M. Levine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel M. Levine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel M. Levine. The network helps show where Rachel M. Levine may publish in the future.

Co-authorship network of co-authors of Rachel M. Levine

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel M. Levine. A scholar is included among the top collaborators of Rachel M. Levine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel M. Levine. Rachel M. Levine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2
Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in micebreakdown →
85
3 8
4 11
5 1
6 46
7 10
8 1
9 19
10 62
11 28
12 8
13 38
14 16
15 42
16 29
17 4
18 4
19 23
20 65

About Rachel M. Levine

Rachel M. Levine is a scholar working on Business and International Management, Genetics and Genetics, having authored 22 papers that have together received 571 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (7 papers), Advanced biosensing and bioanalysis techniques (5 papers) and CRISPR and Genetic Engineering (4 papers). The work is most often cited by research in Biomaterials (83 citations), Business and International Management (12 citations) and Geriatrics and Gerontology (22 citations). Rachel M. Levine has collaborated with scholars based in United States and Netherlands. Frequent co-authors include Efrosini Kokkoli, Eric P. Krenning, Maroof M. Adil, Kenneth H. Cowan, Merrill E. Goldsmith, Timothy R. Pearce, Arthur W. Nienhuis, EC Douglass, Neil J. Clendeninn and Susan C. Aitken. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026